A therapeutic window for preventive therapy in NF1-associated optic pathway glioma
Yuan Zhu,Wang Zheng,Emmanuelle S. Jecrois,Brianna R. Pierce,Daniel M. Treisman
DOI: https://doi.org/10.1080/23723556.2021.1989262
2021-11-02
Abstract:Pediatric low-grade gliomas (pLGGs) are almost universally driven by abnormal activation of RAS-mediated MEK-ERK/MAPK signaling pathway. pLGGs predominantly occur in children, suggesting that they originate in an ERK-dependent neural stem/progenitor population(s) transiently present in the developing brain. Our recent preclinical study reveals a cell-lineage-of-origin and develops a chemopreventative therapeutic strategy.
What problem does this paper attempt to address?